Your browser doesn't support javascript.
loading
Efficacy and safety of Efavirenz 400 mg-based regimens switching from 600 mg-based regimens in people living with HIV with virological suppression in China: a randomized, open-label, non-inferiority study.
Xiao, Jing; Xiao, Jiang; Liu, Ying; Li, Bei; Zhang, Leidan; Han, Junyan; Zhao, Hongxin.
Afiliación
  • Xiao J; Peking University Ditan Teaching Hospital, Beijing, 100015, China.
  • Xiao J; National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China; Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
  • Liu Y; National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China; Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
  • Li B; National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China; Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
  • Zhang L; Peking University Ditan Teaching Hospital, Beijing, 100015, China.
  • Han J; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China; Beijing Institute of Infectious Diseases, Beijing, 100015, China; National Center for Infectious Diseases, Beijing Ditan Hospital, Cap
  • Zhao H; Peking University Ditan Teaching Hospital, Beijing, 100015, China; National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China; Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 10
Int J Infect Dis ; 117: 48-55, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35108610

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Canadá